Efficacy and Safety of Atacicept in IgA Nephropathy
Clinical trial NCT02808429 · TERMINATED
Trial details
- NCT number
- NCT02808429
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-31
- Primary completion
- 2020-02-07
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.